Gadobenate dimeglumine (Gd-DTPA) vs gadopentetate dimeglumine (Gd-BOPTA) for contrast-enhanced magnetic resonance angiography (MRA): Improvement in intravascular signal intensity and contrast to noise ratio;Gadobenato dimeglumina (Gd-DTPA) vs gadopentato dimeglumina (Gd-BOPTA) nell'angiografia con risonanza magnetica: Miglioramento dell'intensità di segnale intravascolare e del rapporto contrasto-rumore

Radiologia Medica

Volumn 106, Issue 1-2, 2003, Pages 87-93

  Pediconi, Federica ^a   Fraioli, Francesco ^a   Catalano, Carlo ^a   Napoli, Alessandro ^a   Danti, Massimiliano ^a   Francone, Marco ^a   Venditti, Fiammetta ^a   Nardis, Piergiorgio ^a   Passariello, Roberto ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Contrast agents; Contrast enhanced MRA; Corotid arteries

Indexed keywords

GADOBENATE DIMEGLUMINE; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE;

ARTICLE; BOLUS INJECTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; FLOW RATE; HUMAN; IMAGE ANALYSIS; IMAGE ENHANCEMENT; IMAGE PROCESSING; IMAGE QUALITY; INTERMETHOD COMPARISON; MAGNETIC RESONANCE ANGIOGRAPHY; OBSERVER VARIATION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SIGNAL NOISE RATIO;

CAROTID STENOSIS; CONTRAST MEDIA; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MEGLUMINE; ORGANOMETALLIC COMPOUNDS; STATISTICS, NONPARAMETRIC;

EID: 0141989915     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Hilal SK: Cerebral hemodynamics assessed by angiography. In: Newton TH, Potts DG, eds. Radiology of the Skull and Brain. St Louis, Mo: Mosby; pp 1057, 1974.
2. Levy RA, Maki JH: Three-dimensional contrast-enhanced MR angiography of the extracranial carotid arteries: two techniques. AJNR 19: 688-690, 1998.
3. Prince MR: Why inject contrast for magnetic resonance angiography? Invest Radiol 33: 483-484, 1998.
4. Prince MR, Arnoldus C, Frisoli JK: Nephrotoxicity of high dose gadolinium compared with iodinated contrast. J Magn Reson Imaging 6: 162-166, 1996.
5. Spinazzi A, Lorusso V, Pirovano G et al: Safety, tolerance, biodistribution and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in non-patient and patient volunteers. Acad Radiol 6: 282-291, 1999.
6. Cavagna FM, Maggioni F, Castelli PM et al: Gadolinium chelates with weak binding to serum proteins. Invest Radiol 32: 780-796, 1997.
7. De Haen C, Cabrini M, Akhana L et al: Gadobenate dimeglumine 0.5M solution for injection (Multihance) pharmaceutical formulation and physicochemical properties of a new magnetic resonance imaging contrast medium. J Comput Assist Tomogr 23 (Suppl 1): S161-168, 1999.
8. Knopp MV: Proceedings of the sixth Meeting of the International Society for Magnetic Resonance in Medicine, 1998.
9. Alexander ME, Baumgartner R, Summers AR et al: A wavelet-based method for improving signal-to-noise ratio and contrast in MR images. Magn Reson Imaging 18: 169-180, 2000.
10. Carrol TJ, Korosec FR, Petermann GM et al: Carotid bifurcation: evaluation of time-resolved three-dimensional contrast-enhanced MR angiography. Radiology 220: 525-532, 2001.
11. Prince MR: Contrast enhanced MR angiography: theory and optimization. Magn Reson Imaging Clin N Am 6: 257-267, 1998.
12. Hany TF, Debatin JF, Leund DA et al: Evaluation of the aortic and renal arteries: comparison of breath-hold, contrast-enhanced, three-dimensional MR angiography with conventional catheter angiography. Radiology 264: 357-362, 1997.